EquityZen Growth Technology Fund LLC - Series 2030
Raised
$566K
Investors
15
Min Invest
$10,064
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2030 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC on 2025-02-27, raising $566K from 15 investors under Rule 506(b) and 3(c)(1) exemptions with a $10K minimum investment. This is part of EquityZen's pre-IPO secondary market platform, which operates 1,889 related EDGAR entities enabling access to private company shares through individual series LLCs.
This pre-IPO fund vehicle uses the standard 506(b)/3(c)(1) exemption pairing typical of private fund offerings with a $10K minimum investment that positions it at the retail-accessible end of the alternative investment spectrum. The raise size and investor count are consistent with EquityZen's platform model of aggregating smaller investors into company-specific SPVs for pre-IPO secondary transactions.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
